candidates

Automobiles Hyundai Motor launches global talent recruitment program

South Korea’s top automaker Hyundai Motor Co. has launched a global talent recruitment program, beginning April 1 via its official hiring webs...

IPOs Celltrion seeks large-scale M&A in Q4, eyes 2027 Nasdaq debut

SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...

Mergers & Acquisitions Macquarie kicks off sale of DIG Airgas estimated at over $3.4 billion

Macquarie Asset Management has embarked on a process to sell off its 100% stake in South Korea’s third-largest industrial gas producer DIG Air...

Mergers & Acquisitions MBK kicks off Lotte Card sale for about $1.4 bn in 2nd bid

Lotte Card Co. is expected to be up for grabs in the first half of next year amid a second sale attempt by its largest shareholder MBK Partners, a N...

Bio & Pharma Hanmi Pharma to move up launch of anti-obesity drug

South Korea’s Hanmi Pharmaceutical Co. announced on Thursday the launch of its anti-obesity drug candidate efpeglenatide has been rescheduled ...

Energy KEPCO shortlisted for Saudi Arabia's solar energy projects

Korea Electric Power Corp. (KEPCO), the South Korean state-run utility company, was shortlisted as a final candidate for renewable energy projects i...

Sovereign wealth funds Sovereign wealth fund KIC shortlists three CEO candidates

South Korean sovereign wealth fund Korea Investment Corporation (KIC) has shortlisted three candidates as the next chief executive officer, who will...

Tech, Media & Telecom KT, Nokia to collaborate on global 6G research

South Korea's KT Corp. announced on Wednesday that it signed a business agreement with global mobile communications equipment manufacturer Nokia Cor...

Airlines MBK, Air Premia team up for Asiana’s cargo unit; Jeju Air exits

South Korea's low-cost carrier Air Premia Inc. has teamed up with North Asia-focused private equity firm MBK Partners to win Asiana Airlines Inc.'s ...

Corporate governance NPS to vote in favor of KT&G CEO candidate Bang

South Korea’s National Pension Service (NPS), the world’s third-largest pension fund, is slated to vote in favor of the KT&G Corp. b...

Corporate governance ISS urges KT&G shareholders to vote against CEO candidate Bang

Global leading proxy advisor Institutional Shareholder Services Inc. (ISS) has recommended that stakeholders of South Korean tobacco maker KT&G ...

Investment banking Korea's NH Investment shortlists 3 CEO candidates

South Korean brokerage house NH Investment & Securities Co. has shortlisted three candidates for its next chief executive as the current CEO Jeo...

Leadership & Management Tobacco maker KT&G names its COO as final CEO candidate

South Korea’s KT&G Corp., the world’s leading tobacco maker, appointed its Chief Operating Officer Bang Kyung-man as the final candi...

Bio & Pharma Samsung Biologics signs ADC CDO deal with LegoChem Bio

Samsung Biologics Co. has agreed with South Korean biotech company LegoChem Biosciences Inc. to provide contract development organization (CDO) serv...

Bio & Pharma LG Chem to start phase 3 for head, neck cancer drug in US

South Korea’s LG Chem Ltd. announced on Wednesday that its US-based subsidiary Aveo Pharmaceuticals will start Phase 3 clinical trials for its...

Bio & Pharma Kobiolabs gets US patent for oral obesity drug candidate

Kobiolabs Co., a South Korean microbiome-based new drug development company, announced on Wednesday that it has a patent for Roseburia intestinalis ...

Bio & Pharma LG Chem out-licenses obesity drug candidate to US firm

LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech...

Leadership & Management POSCO Holdings’ Chairman Choi to hand over baton

POSCO Holdings Inc.'s Chairman Choi Jeong-woo is not among the company’s next CEO candidates, suggesting Choi will leave the company after ser...

Tech, Media & Telecom Korea’s 6G frequency bands picked as standard candidates

Sixth-generation (6G) communication frequency bands proposed by South Korea have been adopted as global standard candidates by the industry's freq...

Bio & Pharma SK Bioscience applies Phase 3 trials in US for pneumococcal vaccine

South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...

Bio & Pharma ISU Abxis gets patent for Alzheimer drug candidate in Taiwan

South Korea's ISU Abxis Co. announced on Friday that its Alzheimer's treatment candidate ISU203 has received a substance patent registration decisio...

Bio & Pharma VaxCell-Bio applies for approval of anti-cancer drug for dogs

South Korea’s VaxCell Biotherapeutics Co. (VaxCell-Bio) on Tuesday announced its application for approval for Vaxleukin-15, an anti-cancer dru...

Bio & Pharma Curocell to localize blood cancer drug by 2025

South Korean biotech company Curocell Inc. on Sunday said it will apply for approval from the Ministry of Food and Drug Safety in September next yea...

Bio & Pharma Humedix gets gov't OK for trials of dementia candidate drug

South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Fo...

Bio & Pharma Ildong Pharma to spin off R&D subsidiary in Nov

South Korea’s Ildong Pharmaceutical Co. will spin off its research and development (R&D) unit into the subsidiary Yunovia from Nov. 1.&nbs...

Bio & Pharma Genome & Co.’s bile duct cancer drug candidate enters Phase 2 trials

Genome & Company, a South Korean developer of microbiome-based drugs, on Tuesday said its GEN-001, a leading immunotherapy drug candidate for bi...

Bio & Pharma Daewoong to develop eye drops for diabetic retinopathy

South Korea's Daewoong Pharmaceutical is venturing into the development of a product that can easily treat diabetic retinopathy in the form of ...

Bio & Pharma Hanmi Science joins race to develop Wegovy competitor

Hanmi Science Co., the holding company of South Korea’s pharmaceutical giant Hanmi Pharmaceutical Co., has joined the global race to develop t...

Mergers & Acquisitions IMM PE invites potential buyers for Genuone worth $752 mn

South Korea’s top-tier contract drugmaker Genuone Sciences Inc. with an estimated value of up to 1 trillion won ($752 million) is smooth saili...

Bio & Pharma Wellmarker Bio signs worth of $528 mn tech transfer deal

Wellmarker Bio, South Korea's oncology drug development company, announced on Monday that it has signed a technology transfer agreement with a Europ...